Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type II pneumocyte | 9 studies | 29% ± 9% | |
| ciliated cell | 9 studies | 33% ± 16% | |
| epithelial cell | 7 studies | 32% ± 18% | |
| epithelial cell of proximal tubule | 5 studies | 22% ± 5% | |
| fibroblast | 5 studies | 27% ± 5% | |
| brush cell | 4 studies | 28% ± 12% | |
| kidney loop of Henle epithelial cell | 3 studies | 19% ± 2% | |
| abnormal cell | 3 studies | 19% ± 4% | |
| dendritic cell | 3 studies | 28% ± 2% | |
| enterocyte | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of PMM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 2060.28 | 1809 / 1809 | 100% | 21.29 | 472 / 472 |
| uterus | 100% | 1749.78 | 170 / 170 | 100% | 15.30 | 458 / 459 |
| brain | 100% | 2240.50 | 2636 / 2642 | 100% | 21.84 | 705 / 705 |
| kidney | 100% | 2904.78 | 89 / 89 | 100% | 23.10 | 898 / 901 |
| prostate | 100% | 1782.46 | 245 / 245 | 100% | 23.16 | 500 / 502 |
| liver | 100% | 2036.43 | 225 / 226 | 100% | 21.12 | 406 / 406 |
| bladder | 100% | 1813.24 | 21 / 21 | 99% | 14.80 | 500 / 504 |
| pancreas | 99% | 1274.93 | 324 / 328 | 100% | 11.97 | 178 / 178 |
| thymus | 100% | 1010.32 | 652 / 653 | 99% | 10.15 | 598 / 605 |
| breast | 100% | 2243.71 | 459 / 459 | 98% | 11.78 | 1101 / 1118 |
| lung | 100% | 2285.89 | 576 / 578 | 98% | 15.80 | 1134 / 1155 |
| adrenal gland | 100% | 2724.20 | 258 / 258 | 97% | 15.49 | 224 / 230 |
| intestine | 100% | 1971.00 | 966 / 966 | 97% | 12.79 | 509 / 527 |
| stomach | 100% | 2693.79 | 359 / 359 | 94% | 10.46 | 270 / 286 |
| esophagus | 100% | 2408.84 | 1445 / 1445 | 93% | 7.25 | 171 / 183 |
| ovary | 100% | 2580.26 | 180 / 180 | 90% | 5.97 | 388 / 430 |
| adipose | 100% | 2476.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 17.17 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 16.44 | 29 / 29 |
| spleen | 100% | 945.34 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.37 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.14 | 1 / 1 |
| blood vessel | 100% | 1878.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 91% | 798.15 | 786 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 84% | 700.41 | 784 / 929 | 0% | 0 | 0 / 0 |
| muscle | 75% | 448.13 | 603 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_0009298 | Biological process | GDP-mannose biosynthetic process |
| GO_0006013 | Biological process | mannose metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0004615 | Molecular function | phosphomannomutase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | PMM1 |
| Protein name | Phosphomannomutase 1 Phosphomannomutase 1 (PMM 1) (EC 5.4.2.8) (PMMH-22) |
| Synonyms | PMMH22 |
| Description | FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. In addition, may be responsible for the degradation of glucose-1,6-bisphosphate in ischemic brain. . |
| Accessions | ENST00000216259.8 F8WFD5 ENST00000414636.1 Q92871 |
